PMID- 11328790 OWN - NLM STAT- MEDLINE DCOM- 20010628 LR - 20190513 IS - 0305-7453 (Print) IS - 0305-7453 (Linking) VI - 47 IP - 5 DP - 2001 May TI - Effect of LY333328 against vancomycin-resistant Enterococcus faecium in a rat central venous catheter-associated infection model. PG - 705-7 AB - A rat central venous catheter (CVC) infection model was used to assess the activity of LY333328 against vancomycin-resistant Enterococcus faecium (VRE). Via the CVC, animals were challenged with 10(6) cfu of Enterococcus faecium with the VanA phenotype. Eight rats received a single dose of LY333328 and eight rats received saline. Seventy-five per cent of control animals had peripheral bacteraemia and 87.5% had VRE recovered from explanted CVCs at the time they were killed, as compared with 0 and 12.5%, respectively, of the LY333328-treated animals (P < 0.01). All animals in the control group had evidence of metastatic disease compared with none of the treated group (P < 0.01). LY333328 was effective against the strain of VRE tested in this model. FAU - Rupp, M E AU - Rupp ME AD - Department of Internal Medicine, 984031 University of Nebraska Medical Center, Omaha, NE 68198-4031, USA. merupp@unmc.edu FAU - Fey, P D AU - Fey PD FAU - Longo, G M AU - Longo GM LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Antimicrob Chemother JT - The Journal of antimicrobial chemotherapy JID - 7513617 RN - 0 (Anti-Bacterial Agents) RN - 0 (Glycopeptides) RN - 0 (Lipoglycopeptides) RN - PUG62FRZ2E (oritavancin) SB - IM MH - Animals MH - Anti-Bacterial Agents/*therapeutic use MH - Catheters, Indwelling/microbiology MH - Disease Models, Animal MH - *Enterococcus faecium/drug effects MH - *Glycopeptides MH - Gram-Positive Bacterial Infections/*drug therapy MH - Lipoglycopeptides MH - Male MH - Prosthesis-Related Infections/*drug therapy MH - Rats MH - Rats, Sprague-Dawley MH - Vancomycin Resistance EDAT- 2001/05/01 10:00 MHDA- 2001/06/29 10:01 CRDT- 2001/05/01 10:00 PHST- 2001/05/01 10:00 [pubmed] PHST- 2001/06/29 10:01 [medline] PHST- 2001/05/01 10:00 [entrez] AID - 10.1093/jac/47.5.705 [doi] PST - ppublish SO - J Antimicrob Chemother. 2001 May;47(5):705-7. doi: 10.1093/jac/47.5.705.